Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
Yonsei Medical Journal
; : 741-749, 2020.
Article
| WPRIM
| ID: wpr-833411
Responsible library:
WPRO
ABSTRACT
Purpose@#Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used in patients with atrial fibrillation (AF) because of their effectiveness in preventing stroke and their better safety, compared with warfarin. However, there are concerns for an increased risk of bleeding associated with concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) or selective serotonin reuptake inhibitors (SSRIs) with NOACs. In this study, we aimed to evaluate the risk of bleeding events in individuals taking concomitant NSAIDs or SSRIs with NOACs after being diagnosed with AF. Materials and